Long-term treatment of rheumatoid arthritis with sulphasalazine: a comparison with auranofin.

スポンサーリンク

概要

• 論文の詳細を見る

• Long-term outcomes of sulphasalazine (SASP) therapy for rheumatoid arthritis (RA) were compared with those of auranofin (AF).Eight of the 41 patients and 6 of the 39 patients who were treated with either SASP or AF stopped each treatment within 3 months because of adverse effects of the agents. Shortterm efficacy, therefore, was compared between the remaining 33 patients received SASP and 33 patients treated with AF: SASP or AF was effective in 79% or 58% of the patients, respectively. There was no significant difference in the incidences of short-term efficacy between SASP-and AF-treated groups. However, SASP more rapidly improved the activities of disease and laboratory parameters such as serum rheumatoid factor levels as compared with AF.Cumulative continuation rates of treatment were compared between SASP-and AF-treated groups by using Kaplan-Meier method. The continuation rates were significantly higher in SASP-treated group within the range from 9 to 18 months after the beginning of treatments than AF-treated group. Thereafter, the rates of both treatments gradually lowered and became almost identical (about 20%).Most of the adverse effects of SASP were mild and developed within one month after the beginning of treatment, although proteinuria developed in some of the AF-treated group several months later.These results support the reported evidence that SASP is an effective and safe treatment for RA, and suggest that SASP is a candidate for the first-choice agent among several slow-acting anti-rheumatic drugs.

• 日本臨床免疫学会の論文

著者

• 清水 宏明

  東海大学内科4

• 有森 茂

  東海大学内科4

• 高屋 正敏

  東海大学内科

• 内山 光昭

  東海大学内科

• 守内 順子

  東海大学内科

• 市川 幸延

  東海大学内科

• 清水 宏明

  東海大学内科

• 有森 茂

  東海大学内科

関連論文

• 運動性無緊張性膀胱をはじめとする多彩な中枢・末梢神経障害を示した全身性エリテマトーデスの1例
• 380 胸腺ならびに胸腺腫での癌遺伝子(c-myc, c-Ki-ras, c-Ha-ras)の発現
• 55 慢性関節リウマチに対するsulphasalazine(Salazopyrin[○!R])の長期治療成績 : 経口金剤(auranofin)との比較
• 54 慢性関節リウマチ、全身性エリテマトーデス、ベーチェット病患者の末梢血、関節液中の腫瘍壊死性因子(TNF-α)
• シェーグレン症候群患者の乾燥症状に対する塩酸ピロカルピンの有用性
• 少量の金剤(gold sodium thiomalate)により間質性肺炎を発症した慢性関節リウマチの1例
• 3種の臓器特異性自己免疫疾患を合併し抗IgA抗体と赤血球結合IgAが陽性であったIgA単独欠損症の1例
• A case report of Coombs' test-negative Evans syndrome associated with subclinical Sjögren's syndrome
• Long-term treatment of rheumatoid arthritis with sulphasalazine: a comparison with auranofin.

スポンサーリンク